Scollr summary
What this paper is about
The diagnostic trajectory for ATTR-CM can be prolonged and challenging, leading to more advanced disease at diagnosis and increased burden.
Full abstract
Read the full abstract
BACKGROUND: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, life-threatening condition. Timely and accurate diagnosis remains a challenge. We assessed time from first recorded clinical manifestation to ATTR-CM diagnosis in the United States and characterized manifestations associated with diagnostic delays. METHODS: Retrospective analysis of US claims data (Komodo Healthcare Map, July 1, 2016-June 30, 2024). Patients were required to have ≥3 years of continuous enrollment before diagnosis. RESULTS: Among 7509 patients, mean age 75.9 years, 63.2% male, 54.5% White, and 28.6% Black. Patients had a median of 8 manifestations before diagnosis; median observed time from first recorded manifestation to diagnosis was 5.2 years, shorter for variant versus wild-type ATTR-CM (4.4 versus 5.2 years). Within 3 years before diagnosis, patients had a mean of 12.04 (95% CI, 11.75-12.35) primary care physician visits and 14.45 (95% CI, 14.10-14.80) specialists of interest visits, most commonly with cardiologists and ophthalmologists. In adjusted analyses, variant ATTR-CM was associated with shorter time to diagnosis (β, -0.41 years [95% CI, -0.56 to -0.26]), whereas comorbidities, including hypertension (β, 0.46 years [95% CI, 0.27-0.64]), were associated with longer delays. CONCLUSIONS: The diagnostic trajectory for ATTR-CM can be prolonged and challenging, leading to more advanced disease at diagnosis and increased burden. Raising awareness may provide an opportunity for earlier diagnosis.
Direct answer
What can I do from this paper page?
Use this page to scan "Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Amyloidosis: Diagnosis, Treatment, Outcomes research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Mitchell2026Delays,
title = {Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study},
author = {Joshua D. Mitchell and Margarita Udall and Liana Hennum and Hanh Dung Dao and Bret Zeldow and Elizabeth Nagelhout and Kevin Michael Alexander and Richard Kar-Hang Cheng},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.048942},
url = {https://doi.org/10.1161/jaha.125.048942}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Amyloidosis: Diagnosis, Treatment, Outcomes research papers?
Follow Amyloidosis: Diagnosis, Treatment, Outcomes research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app